Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 584

Results For "IND"

6833 News Found

DefiniGen promotes Dr Chris Kirton to CEO
People | January 21, 2022

DefiniGen promotes Dr Chris Kirton to CEO

The appointment is key for DefiniGEN as they expand the service portfolio to encompass compound screening


Biocon consolidated PAT at Rs 187.1 cr. in Q3FY22
News | January 21, 2022

Biocon consolidated PAT at Rs 187.1 cr. in Q3FY22

Biocon has reported consolidated financial results for the period ended December 31, 2021


SEC recommends regular market approval for Covishield and Covaxin
News | January 20, 2022

SEC recommends regular market approval for Covishield and Covaxin

However, these won’t be available at the nearest chemist store soon


Dolomite Bio announce launch of cost-effective Bioinformatics service
Biotech | January 20, 2022

Dolomite Bio announce launch of cost-effective Bioinformatics service

Unlike most data analysis services, Dolomite Bio will accept sample sizes ranging from as little as one sample, to as many as the research project requires


Australia grants provisional registration for Novavax Covid-19 vaccine
Drug Approval | January 20, 2022

Australia grants provisional registration for Novavax Covid-19 vaccine

Nuvaxovid is the first protein-based Covid-19 vaccine to receive approval for provisional registration in Australia


VFMCRP receives EU approval for Tavneos for the treatment of ANCA-associated vasculitis
Drug Approval | January 20, 2022

VFMCRP receives EU approval for Tavneos for the treatment of ANCA-associated vasculitis

First launches expected in H1 2022


Green chemistry approaches to synthesis could make a big difference to pharma product outputs
News | January 20, 2022

Green chemistry approaches to synthesis could make a big difference to pharma product outputs

Bio-catalysis and Electro-catalysis emerge as most preferred green chemistry technologies


Natco Pharma signs agreement with Medicines Patent Pool
News | January 20, 2022

Natco Pharma signs agreement with Medicines Patent Pool

This agreement allows Natco to expand access to Covid-19 medicines in 105 countries in generic name


Strides Pharma and subsidiary Universal Corporation enters tie-up with Medicines Patent Pool
News | January 20, 2022

Strides Pharma and subsidiary Universal Corporation enters tie-up with Medicines Patent Pool

They will commercialize molnupiravir in the international markets


Max Healthcare to add over 300 beds in NCR ties up with Muthoot Hospitals
Hospitals | January 20, 2022

Max Healthcare to add over 300 beds in NCR ties up with Muthoot Hospitals

The hospital will be operated under the name and style of Max Super Speciality Hospital, Dwarka